Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02910934 |
Date of registration:
|
19/09/2016 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique
COST |
Scientific title:
|
Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique |
Date of first enrolment:
|
January 10, 2017 |
Target sample size:
|
3915 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02910934 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: Single (Outcomes Assessor).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Mozambique
|
United States
| | | | | | |
Contacts
|
Name:
|
Molly Robertson, MA, MPH |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
PATH |
|
Name:
|
Carlos Chaccour, MD, MSc, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Barcelona Institute for Global Health |
|
Name:
|
Abuchama Saifodine, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
US Presidents Malaria Initiative, USAID |
|
Name:
|
Francisco Saute, Md, MSc, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Centro de Investigacoes de Manhica |
|
Name:
|
Rose Zulliger, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
US Presidents Malaria Initiative, Centers for Disease Control and Prevention |
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- all consenting adults, assenting minors (12-18) and caregivers of children under 12
Exclusion Criteria:
- all infants 0-6 months of age
Age minimum:
6 Months
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Malaria
|
Intervention(s)
|
Other: Actellic CS
|
Primary Outcome(s)
|
Cost per case averted in children five years of age and under at health facility level by adding Actellic-IRS
[Time Frame: 24 months]
|
Secondary Outcome(s)
|
Cost per malaria case averted in children five years of age and under at the community
[Time Frame: 24months]
|
Entomological Indicators
[Time Frame: 24 months]
|
Parasite prevalence
[Time Frame: 12 months]
|
Health Behavior
[Time Frame: 24 months]
|
Secondary ID(s)
|
946238-1 (EOM)
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|